When patients and their families need help following a diagnosis or throughout treatment, the Meso Foundation is there for them – day or night. But…
On July 24, the U.S. House of Representatives passed a Defense Funding Bill that included $16 million in funding that is eligible to be awarded…
Last week, the Journal of Thoracic Oncology published the results of a study looking into the overexpression of the ephrin B2 receptor (EPHB2) in patients…
If you are a federal employee (including military personnel), you are eligible to participate in the Combined Federal Campaign’s (CFC) fundraising drive. The CFC allows…
by Laurie Kazan-Allen The publication of an article entitled “Mesothelioma – The British Disease” in mid-June, 2013 set the tone for a summer of legislative,…
by Erica Ruble, Fundraising Coordinator, Mesothelioma Applied Research Foundation I lost my hero and father, Lance S. Ruble, to mesothelioma on August 16, 2008. Determined…
Recently, we had the honor to interview Melissa Culligan, RN, BSN, MS, a thoracic surgery nurse with specialized experience designing clinical trials. To listen press…
Meso Foundation’s executive director, Mary Hesdorffer, Nurse Practitioner, is in London and wanted to share with you that she just spoke at the annual asbestos seminar…
Personalized medicine is the ability to select a biologic target and direct therapy against this target. It is associated with improved outcomes in a number…
by Mary Hesdorffer, Nurse Practitioner Executive Director, Mesothelioma Applied Research Foundation Researchers from Creighton University School of Medicine accessed the National Cancer Database (NCD), and…